Consider participating in our Hypothyroidism research study for people aged 18-75 years. The study may be suitable for you if you have been taking daily Levothyroxine. Oher criteria apply. You may be compensated for your participation in the study.
The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare is enrolling a research study evaluating an investigational preventive treatment of migraine in children and teens ages 6 – 17.
Accellacare offers research participation options for those with MS such as advancing current treatments, finding new therapies, and addressing associated symptoms.
The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare has multiple options available to participate in migraine trials.
The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare is enrolling a research study evaluating an investigational preventive treatment of migraine in children and teens ages 6 – 17.
This one-visit research study is evaluating blood samples collected from those with various types of thyroid/autoimmune diseases. Results will aid in understanding biomarkers associated with autoimmune thyroid diseases.
Accellacare is enrolling adults for a vaccine research study. Eligible participants will receive study-related care and study vaccine at no cost. Financial compensation will also be provided for time and travel expenses.
Accellacare provides options for health adults over 18 to be a part of medical advancements. Eligible participants will receive study-related care and financial compensation for time and travel.
Accellacare provides options for health adults over 18 to be a part of medical advancements. Eligible participants will receive study-related care and financial compensation for time and travel.
Learn more about research opportunities in dermatology. Currently, Accellacare is looking for patients who are interested to participate in studies for a variety of skin conditions and ailments. Eligible participants will receive financial compensation and study related care at no cost. Refer an eligible friend to receive $50.
By getting a vaccine, you could also support research.
Adults 18 years or older (medically stable).
Other criteria apply.
All eligible participants will receive a seasonal illness vaccine, study-related care at no cost, and financial compensation for time and travel expenses.
Learn more about your cholesterol levels by taking part in a Cardiovascular Disease research study. People living with cardiovascular disease may be eligible, other criteria apply. Reimbursement for travel and expenses may be available.
Accellacare is enrolling volunteers to evaluate an investigational medication for type 2 diabetes. Eligible volunteers will receive study-related care and medication at no cost. Financial compensation will also be provided for time and travel expenses.
Accellacare saw a need for a patient feedback and engagement program that gives patients a voice directly to the industry, to help create a truly patient-centric clinical research environment. The answer was The Patient Voice program.
Know someone who may benefit from research participation? Provide your referrals* below and we will contact them about their volunteer options. If they qualify, you will receive a gift card as a thank you.
Sarcoma is a rare type of cancer that forms in the connective tissues of the body, such as bones, muscles, fat, and cartilage. Sarcoma Awareness Month, observed in July, aims to raise awareness, support patients and families, and promote research to improve treatments and outcomes for those affected by this aggressive cancer.
Each year on July 5th, we celebrate the dedication and achievements of researchers who work tirelessly to advance knowledge, improve health outcomes, and make a lasting difference in society.